Vanguard Global Advisers
VCYT icon

Vanguard Global Advisers’s Veracyte VCYT Stock Holding History

Vanguard Global Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Sell
30,605
-906
-3% -$38K ﹤0.01% 1330
2026
Q1 		$1.01M Buy
+31,511
New +$1.17M ﹤0.01% 1651

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Global Advisers's VCYT Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Veracyte (VCYT) stake by 2.9% in Q2 2026, selling an estimated $38K and leaving 30,605 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

Vanguard Global Advisers first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 367 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Vanguard Global Advisers held 30,605 shares of Veracyte worth $1.8M as of Q2 2026.
  • Vanguard Global Advisers sold 906 Veracyte shares in Q2 2026, an estimated $38K.
  • Veracyte made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1330 holding.
  • Vanguard Global Advisers first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 367 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.